Free webinar examines chemotherapy in practice

Free webinar examines chemotherapy in practice

An upcoming webinar aims to give vets a better understanding of the latest thinking on the use of chemotherapy in practice

The Confident Chemotherapy webinar, hosted by BBraun Vetcare,  will also look at how the adoption of Closed System Transfer Devices, such as Tevadaptor®, can help to improve safety and break down barriers to treatment across all practices.

The free webinar, aimed at both veterinary surgeons and nurses, will take place on Thursday, July 15 and is being run in collaboration with world-class speakers and referral centres specialising in small animal oncology.

Speakers include Professor Melissa McDermid MD, MPH, division head, Occupational & Environmental Medicine, University of Maryland; Prof. Clare Knottenbelt BVSC MSC DSAM MRCVS, owner and founder of specialist referral service, Hawk and Dove, and previously clinical director of the Small Animal Hospital at the University of Glasgow Veterinary School and Sam Fontaine MSc, lecturer and director of the MSc Advanced Practice in Veterinary Nursing and module leader within the BVMS programme at The Glasgow School of Veterinary Medicine. The online seminar also features a video from the oncology centre at The Queen’s Veterinary School, Cambridge University.

Delegates will also have the chance to submit questions to the speakers and will receive a certificate for one hour of CPD, with the whole thing recorded so it can be watched again.

Prof. Knottenbelt said: “Pets with cancer need to be able to access chemotherapy treatments locally.  The advent of new closed administration systems mean that practices can now safely administer chemotherapeutics in house without the need for large investment, but still protecting the health of their staff.”

The full programme and registration details for the Confident Chemotherapy webinar can be found via the Event Brite registration link:  A CPD certificate will be sent to the registered email address after the webinar has been viewed.

Sign up to our newsletter here >>>>